Summary
- Current Price
- As of today, ANAB price is $46.61, down -4.31% on
- Current Price All-Time High
- ANAB price is currently -47.82% below its historical high of $89.33 set on
- Market Cap
- ANAB current market cap is $1B, up +120.34% over the past 365 days
- PE Ratio
- ANAB current PE ratio is 7.23
- Revenue
- ANAB current annual revenue is $234.60M, up +157.01% year-over-year
- Next Earnings
- The next earnings release for ANAB is on
Profile
| Metric | Value |
|---|---|
| Full Name | AnaptysBio, Inc. |
| Ticker | NASDAQ: ANAB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | anaptysbio.com |
| Employees | 136 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $46.61 | |
| Price, 1D Change | -4.31% | |
| $1B | ||
| - | ||
| 7.23 | ||
| 0.88 | ||
| $234.60M | ||
| Revenue, 1Y Change | +157.01% | |
| -$0.46 | ||
| EPS, 1Y Change | +91.01% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 3:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.46 | ||
| EPS Estimate | $4.35 | N/A |
| EPS Est. Change | +1,045.51% | N/A |
| $234.60M | ||
| Revenue Estimate | $101.12M | N/A |
| Revenue Est. Change | -56.90% | N/A |
| Current Price | $46.61 | |
| Price Target | $79.50 | - |
| Price Tgt. Change | +70.56% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$6.18 | -$5.12 | +17.21% | |
| -$1.45 | -$0.46 | +68.18% | |
| $4.35 | N/A | +1,045.51% | |
| $5.07 | N/A | +1,201.56% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $55.93M | $91.28M | +63.22% | |
| $205.31M | $234.60M | +14.27% | |
| $101.12M | N/A | -56.90% | |
| $171.31M | N/A | -26.98% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $46.61 | |
| $49.52 | ||
| $53.57 | ||
| $48.16 | ||
| $52.02 | ||
| -$2.10 | ||
| 0.88 | ||
| $2.10 | ||
| 37.34 | ||
| 46.03% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $234.60M | ||
| -$0.46 | ||
| $232.18M | ||
| 98.97% | ||
| $47.90M | ||
| 20.42% | ||
| -$13.23M | ||
| -5.64% | ||
| $50.32M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 7.81 | ||
| 9.07 | ||
| 9.07 | ||
| - | ||
| 5 | ||
| 1.69 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 7.23 | ||
| 5.86 | ||
| 131.64 | ||
| 11.01 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $37.21M | ||
| $311.64M | ||
| $364.40M | ||
| $350.25M | ||
| $327.19M | ||
| $38.63M | ||
| $290.64M | ||
| $2.08M | ||
| $3.87M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $247.84M | ||
| $184.28M | ||
| $2.42M | ||
| $0.00 | ||
| $2.42M | ||
| $0.00 | ||
| $164.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $19.70M | ||
| $228.03M | ||
| -$132.61M | ||
| $87.00K | ||
| $19.61M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| Barclays | → | |
| Piper Sandler | → | |
| Leerink Partners | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ANAB
FAQ
- What is the ticker symbol for AnaptysBio, Inc.?
- The ticker symbol for AnaptysBio, Inc. is NASDAQ:ANAB
- Does AnaptysBio, Inc. pay dividends?
- No, AnaptysBio, Inc. does not pay dividends
- What sector is AnaptysBio, Inc. in?
- AnaptysBio, Inc. is in the Healthcare sector
- What industry is AnaptysBio, Inc. in?
- AnaptysBio, Inc. is in the Biotechnology industry
- What country is AnaptysBio, Inc. based in?
- AnaptysBio, Inc. is headquartered in United States
- When did AnaptysBio, Inc. go public?
- AnaptysBio, Inc. initial public offering (IPO) was on January 26, 2017
- Is AnaptysBio, Inc. in the S&P 500?
- No, AnaptysBio, Inc. is not included in the S&P 500 index
- Is AnaptysBio, Inc. in the NASDAQ 100?
- No, AnaptysBio, Inc. is not included in the NASDAQ 100 index
- Is AnaptysBio, Inc. in the Dow Jones?
- No, AnaptysBio, Inc. is not included in the Dow Jones index
- When was AnaptysBio, Inc. last earnings report?
- AnaptysBio, Inc.'s most recent earnings report was on May 12, 2026
- When does AnaptysBio, Inc. report earnings?
- The next expected earnings date for AnaptysBio, Inc. is November 3, 2026
Data Sources & References
- ANAB Official Website www.anaptysbio.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1370053/000119312526088290/0001193125-26-088290-index.htm
- ANAB Profile on Yahoo Finance finance.yahoo.com/quote/ANAB
- ANAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anab
